<DOC>
	<DOCNO>NCT00163280</DOCNO>
	<brief_summary>This purpose study investigate whether ATL-104 safe well tolerate , whether show evidence efficacy mucositis patient undergoing PBSCT</brief_summary>
	<brief_title>Safety , Tolerability Efficacy ATL-104 Oral Mucositis</brief_title>
	<detailed_description>Mucositis serious side effect cancer therapy Peripheral Blood Stem Cell Transplant ( PBSCT ) require appropriate effective management . Mucositis condition inflammation ulceration mouth , throat gut cause damage mucosal barrier induce chemo- radiotherapy . Symptoms include pain , nausea , abdominal cramping , vomit . This study investigate whether ATL-104 , administer swallowable mouthwash , safe well tolerated patient undergo PBSCT investigate potential reduce level severity mucositis associate PBSCT .</detailed_description>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>Patients haematological malignancy undergo chemotherapy association PBSCT Clinically significant condition would exclude patient receive chemotherapy association PBSCT Visible oral disease Significantly reduce platelet neutrophil count</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2008</verification_date>
	<keyword>Mucositis</keyword>
	<keyword>Peripheral blood stem cell transplant</keyword>
</DOC>